Zantac Pancreatic Cancer
Chicago Personal Injury Lawyers

Zantac was recently removed from the market (along with other ranitidine products) based on the drug’s association with NDMA (N-Nitrosodimethylamine) – a probable carcinogen. This association is so concerning that some manufacturers of generic equivalents had already pulled their versions, and several large drugstore chains had already dropped the medications months earlier. Pancreatic cancer is one of the cancers that’s closely associated with NDMA.

Pancreatic Cancer

Pancreatic cancer is a rare form of cancer that forms in the pancreas and that is difficult to detect in its early stages. Once advanced, the disease becomes much more difficult to treat. Prevailing scientific evidence points to a connection between NDMA and pancreatic cancer.

The symptoms associated with more advanced stages of pancreatic cancer as advanced by the Mayo Clinic include:

• Loss of appetite and attendant unintentional weight loss
• Fatigue
• Blood clots
• Itchy skin
• Yellowing of the skin and the whites of the eyes (jaundice)
• Light-colored stools and/or dark-colored urine
• Abdominal pain that radiates around the back
• A new diagnosis of diabetes or an existing condition that’s become more difficult to control

Zantac

Zantac is a very popular and profitable medication that has been on the market for decades and that continued to be widely used until the recent market withdrawals. Had consumers been forewarned, they could have at least made better-informed decisions regarding the drug’s side effects.

Call an Experienced Drug Injury Lawyer Today

If you’ve been diagnosed with pancreatic cancer after being a regular user of Zantac, discuss your concerns and the possible connection with a formidable drug injury lawyer today.